Cloud Capital Management’s Haemonetics HAE Stock Holding History

Cloud Capital Management’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3	Closed	–	–	695
2025 Q3	$0	Buy	+3	New	+$186	﹤0.01%	1219

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cloud Capital Management's HAE Position: Q4 2025 in Review

Cloud Capital Management sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 3 shares.

Cloud Capital Management first reported a position in HAE in Q3 2025 and held it in 1 quarter. The position peaked at $0 in Q3 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

Cloud Capital Management reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
Cloud Capital Management sold 3 Haemonetics shares in Q4 2025.
Cloud Capital Management first reported a position in Haemonetics in Q3 2025 and held it in 1 quarter.
Cloud Capital Management's Haemonetics position peaked at $0 in Q3 2025.
329 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Cloud Capital Management's 13F filing for Q4 2025, filed 12 Feb 2026.